Table II.
Effect of treatment with a combination of YQYYT-containing serum and DNR on proliferation of KG1a cells.
| Control serum | YQYYT-containing serum | ||||
|---|---|---|---|---|---|
| Groups | Time (h)a | OD value, mean ± SD | Inhibition rate (%) | OD value, mean ± SD | Inhibition rate (%) |
| Blank | 24+24 | 0.97±0.06 | – | 1.01±0.05 | – |
| 24+48 | 1.35±0.01 | – | 0.31±0.02 | – | |
| DNR | 24+24 | 0.52±0.01 | 49.2 | 0.52±0.01 | 48.6 |
| 24+48 | 0.71±0.06 | 46.8 | 0.67±0.04 | 49 | |
| 5 µl serum +DNR | 24+24 | 0.49±0.01 | 46.7 | 0.50±0.01 | 50.1 |
| 24+48 | 0.74±0.04 | 45.1 | 0.67±0.03 | 48.5 | |
| 10 µl serum +DNR | 24+24 | 0.49±0.02 | 48.8 | 0.48±0.02 | 52.1 |
| 24+48 | 0.76±0.05 | 47.3 | 0.70±0.05 | 56.5 | |
| 20 µl serum +DNR | 24+24 | 0.48±0.03 | 49.6 | 0.45±0.01 | 53.9 |
| 24+48 | 0.78±0.04 | 43.3 | 0.54±0.02 | 58.9a | |
| 40 µl serum +DNR | 24+24 | 0.51±0.02 | 50.6 | 0.40±0.01 | 60.4a |
| 24+48 | 0.69±0.02 | 48.8 | 0.37±0.03 | 72.5b | |
n=3
a
P<0.05 vs. DNR group
b
P<0.01 vs. DNR group. DNR, daunorubicin; OD, optical density; SD, standard deviation; YQYYT, yi-qi-yang-yin-tang. aThe first number refers to the duration of treatment with the control serum and the second number refers to the duration of treatment with the YQYYT-containing serum.